SynBioBeta, a major gathering of the biotech world scheduled for earlier this month in San Jose, Calif. As the discussion’s ...
Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the first quarter ended March 31, 2026. "The Bionano business is healthy, with first ...
Genomics provides advanced tools for single cell and spatial biology research, serving academic and biopharma institutions ...
Structural genomics projects aim to solve the experimental structures of all possible protein folds. Such projects entail a conceptual shift from traditional structural biology in which structural ...
Time to Invest? 10x Genomics (NASDAQ:TXG) reported a first-quarter revenue increase excluding prior-year settlement revenue ...
Fiscal 2026 Outlook and Atara Launch Dynamics Full-year 2026 revenue guidance of $600 million to $625 million assumes ...
PLEASANTON, Calif., May 7, 2026 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today reported financial results for ...
Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today reported financial results for the first ...
Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that Al Luderer, Ph.D., chairman of Bionano’s Board of Directors, has been appointed interim president and chief executive officer, effective May ...
The alternative text for this image may have been generated using AI. In this review we summarize some areas of molecular evolution research in which genomics has had a strong impact in the past ...
Background Establishing best practice recommendations helps to increase consistency, equity and innovation in clinical genomics services. Bioinformatics approaches are a core component of clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results